Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

计划入组 45 人 · 首次发布于 2022 年 8 月 11 日

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

计划入组 51 人 · 首次发布于 2019 年 11 月 4 日

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

计划入组 52 人 · 首次发布于 2017 年 6 月 16 日

ARNI program (Theravance)

TD-7601

Sacubitril(Entresto, Neparvis)

C₂₄H₂₉NO₅

Theravance Biopharma

Neprilysin Gene Transfer Shows Promise in Reducing Alzheimer's Amyloid-Beta Levels and Improving Cognition

Dopamine's Surprising Breakthrough in Alzheimer's Treatment

FDA Approves Vostally Oral Solution, First Liquid Ramipril Formulation for Hypertension Treatment